Navigation Links
Encision Pursues Transfer of Quotation to OTC Bulletin Board
Date:10/14/2008

BOULDER, Colo., Oct. 14 /PRNewswire-FirstCall/ -- Encision Inc. (Pink Sheets: ECIA) ("Encision," or the "Company"), a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, announced today that the Company is in the process of transferring the quotation of its common stock to the OTC Bulletin Board ("OTCBB") and that it has identified a sponsoring market maker who will make an application to quote the common stock of Encision on the OTCBB. The Company's directors, executives and 10% shareholders have filed information with the market maker.

Trading of the Company's common stock on the OTCBB, which is maintained by the Financial Industry Regulatory Authority ("FINRA"), is subject to a market maker's filing of a Form 211 with, and the clearance of such Form 211 by, FINRA. We expect that the market maker will file a Form 211 with FINRA to seek clearance to quote the Company's common stock on the OTCBB within ten days. The Company's common stock is currently quoted on the Pink Sheets, an electronic quotation service for securities traded over-the-counter, and will continue to be quoted on the Pink Sheets.

Jack Serino, President and CEO of Encision, said, "The Company is aggressively pursuing quotation of its common stock on the OTCBB. Until the market maker files the Form 211 and FINRA clears the Company's common stock for quotation on the OTCBB we will, in the interim, trade on the Pink Sheets. The Company will endeavor to operate in compliance with the reporting requirements for the OTCBB, which will include continuing to file with the SEC and all other applicable regulatory authorities."

There can be no assurance that the Company's common stock will be granted eligibility to be quoted on the OTCBB. Quotation on the OTCBB requires companies to be current in their filings with the SEC. The Company believes that it is current with its filings with the SEC and all other applicable regulatory authorities.

Encision Inc. designs, develops, manufactures and markets innovative surgical devices that allow surgeons to optimize technique and patient safety during a broad range of surgical procedures. Based in Boulder, Colorado, the Company pioneered the development of patented AEM(R) Laparoscopic Instruments to improve electrosurgery and reduce the chance for patient injury in minimally invasive surgery.

In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the Company notes that statements in this press release and elsewhere that look forward in time, which include everything other than historical information, involve risks and uncertainties that may cause actual results to differ materially from those indicated by the forward- looking statements. Factors that could cause the Company's actual results to differ materially include, among others, its ability to increase revenues through the Company's distribution channels, insufficient quantity of new account conversions, insufficient cash to fund operations, scale up production to meet delivery obligations, delay in developing new products and receiving FDA approval for such new products and other factors discussed in the Company's filings with the Securities and Exchange Commission.

CONTACT: Marcia McHaffie, Encision Inc., 303-444-2600, mmchaffie@encision.com


'/>"/>
SOURCE Encision Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Encision Reports First Fiscal Quarter Results
2. Encision Reports Fourth Quarter and Fiscal Year 2008 Results
3. Encision Moves Power and Safety to Surgeons Fingertips
4. Encision Supports National Patient Safety Awareness Week
5. Encision Reports Third Fiscal Quarter Results
6. American Stock Exchange Accepts Encisions Plan to Regain Compliance
7. Gene-Transfer Proves Safe for Vision Problem
8. AUA 2008: Maxi-K gene transfer may prove to be safe and effective erectile dysfunction treatment
9. California Nursing Home, Homecare Workers Vote Overwhelmingly to Preempt Forced Transfer
10. Barrier Technology Provides New Weapon in MRSA War: Surface Care Products Prevent Growth and Transfer of Bacteria
11. Roche Engages in Four Additional AIDS Technology Transfers to Strengthen Local Manufacturing in Worlds Poorest Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... The International Association of Eating Disorders ... for the field of eating disorders, announces the opening of early registration for ... Florida at the Omni Resort at ChampionsGate. , The annual iaedp™ ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)...  BioPharmX Corporation (NYSE MKT: BPMX) researchers were part ... way to use nonlinear optical imaging to confirm the ... A presentation ... how researchers from BioPharmX and the Wellman Center for ... suite of imaging techniques in what is called "Pharmacokinetic ...
(Date:10/10/2017)... 10, 2017   West Pharmaceutical Services, Inc. ... injectable drug administration, today shared the results of a ... improving the intradermal administration of polio vaccines. The study ... in May 2017 by Dr. Ondrej Mach , ... Health Organization (WHO), and recently published in the journal ...
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
Breaking Medicine Technology: